SOX9 Is Highly Expressed in Nonampullary Duodenal Adenoma and Adenocarcinoma in Humans
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: SOX9 is a marker for stem cells in the intestine, and overexpression of SOX9 is found in gastric and colon cancer; however, the expression of SOX9 in nonampullary duodenal adenoma and adenocarcinoma has not yet been evaluated. This study aimed to investigate SOX9 expression in nonampullary duodenal adenoma and adenocarcinoma by immunohistochemistry. Methods: We evaluated SOX9 expression in 43 clinical samples (nonampullary duodenal adenoma in 22 lesions and nonampullary duodenal adenocarcinoma in 21 lesions) resected under endoscopic mucosal resection or endoscopic submucosal dissection. Results: SOX9 was expressed in part of the base of the normal duodenal mucosa surrounding adenomas and adenocarcinomas. In contrast, SOX9-positive cells were found in more than half of the crypts from the bottom part of the crypt in all of the 43 samples. Moreover, in 15 adenoma samples (68.2%) and 19 carcinoma samples (90.5%), SOX9was expressed in more than three-quarters of the crypts from the bottom part of the crypt. Conclusions: SOX9 is overexpressed in nonampullary duodenal adenoma and adenocarcinoma in humans.
Abstract
Background/Aims: SOX9 is a marker for stem cells in the intestine, and overexpression of SOX9 is found in gastric and colon cancer; however, the expression of SOX9 in nonampullary duodenal adenoma and adenocarcinoma has not yet been evaluated. This study aimed to investigate SOX9 expression in nonampullary duodenal adenoma and adenocarcinoma by immunohistochemistry. Methods: We evaluated SOX9 expression in 43 clinical samples (nonampullary duodenal adenoma in 22 lesions and nonampullary duodenal adenocarcinoma in 21 lesions) resected under endoscopic mucosal resection or endoscopic submucosal dissection. Results: SOX9 was expressed in part of the base of the normal duodenal mucosa surrounding adenomas and adenocarcinomas. In contrast, SOX9-positive cells were found in more than half of the crypts from the bottom part of the crypt in all of the 43 samples. Moreover, in 15 adenoma samples (68.2%) and 19 carcinoma samples (90.5%), SOX9was expressed in more than three-quarters of the crypts from the bottom part of the crypt. Conclusions: SOX9 is overexpressed in nonampullary duodenal adenoma and adenocarcinoma in humans.
참고문헌 (24)
- Jepsen JM, "Prospective study of prevalence and endoscopic and histopathologic characteristics of duodenal polyps in patients submitted to upper endoscopy", Scand J Gastroenterol, 29, pp.483~487 (1994)
- Dabaja BS, "Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients", Cancer, 101, pp.518~526 (2004)
- Kalogerinis PT, "Duodenal carcinoma at the ligament of Treitz. A molecular and clinical perspective", BMC Gastroenterol, 10, pp.109~ (2010)
- Oka S, "Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma", J Clin Gastroenterol, 37, pp.381~386 (2003)
- Alexander S, "EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos)", Gastrointest Endosc, 69, pp.66~73 (2009)
- Honda T, "Endoscopic submucosal dissection for superficial duodenal neoplasms", Dig Endosc, 21, pp.270~274 (2009)
- Abbass R, "Nonampullary duodenal polyps: characteristics and endoscopic management", Gastrointest Endosc, 71, pp.754~759 (2010)
- Okada K, "Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance", Am J Gastroenterol, 106, pp.357~364 (2011)
- Blache P, "SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes", J Cell Biol, 166, pp.37~47 (2004)
- Jay P, "Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells", Cancer Res, 65, pp.2193~2198 (2005)
- Furuyama K, "Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine", Nat Genet, 43, pp.34~41 (2011)
- Bastide P, "Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium", J Cell Biol, 178, pp.635~648 (2007)
- Reya T, "Wnt signalling in stem cells and cancer", Nature, 434, pp.843~850 (2005)
- Lu B, "A transcriptome anatomy of human colorectal cancers", BMC Cancer, 6, pp.40~ (2006)
- Lu B, "Analysis of SOX9 expression in colorectal cancer", Am J Clin Pathol, 130, pp.897~904 (2008)
- Sashikawa Kimura M, "SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans", J Gastroenterol, 46, pp.1292~1299 (2011)
- Mutoh H, "Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice", Biochem Biophys Res Commun, 294, pp.470~479 (2002)
- Sakamoto H, "Intestinal metaplasia in gallbladder correlates with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary duct", Hum Pathol, 40, pp.1762~1767 (2009)
- Shih IM, "Top-down morphogenesis of colorectal tumors", Proc Natl Acad Sci U S A, 98, pp.2640~2645 (2001)
- Preston SL, "Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission", Cancer Res, 63, pp.3819~3825 (2003)
- Jiang SS, "Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity", Clin Cancer Res, 16, pp.4363~4373 (2010)
- Chakravarty G, "Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer", Exp Biol Med (Maywood), 236, pp.145~155 (2011)
- Ling S, "An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer", Cancer Res, 71, pp.3812~3821 (2011)
- Mazur PK, "Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer", Am J Gastroenterol, 107, pp.126~135 (2012)